MODULATION OF ANTIMONY MEDIATED THERAPY FOR AN OPTIMAL INSULIN SECRETION DURING VISCERAL LEISHMANIASIS

被引：0
|
作者：
Sinha, Sukrat [1 ]
机构：
[1] Nehru Gram Bharati Univ, Hanuman Ganj, Uttar Pradesh, India
来源：
GUT | 2019年 / 68卷
关键词：
D O I：
10.1136/gutjnl-2019-IDDFabstracts.183
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2019-A
引用
收藏
页码：A97 / A97
页数：1
相关论文
共 50 条
  • [1] AGRANULOCYTOSIS DURING A VISCERAL LEISHMANIASIS TREATED BY ANTIMONY
    BOUREE, P
    DULAC, O
    ARCHIVES FRANCAISES DE PEDIATRIE, 1977, 34 (07): : 659 - 661
  • [2] Conduction defect following pentavalent antimony therapy in visceral leishmaniasis
    Ahasan, HAMN
    Chowdhury, MAJ
    Azhar, MA
    Rafiqueuddin, AKM
    Islam, MF
    TROPICAL DOCTOR, 1997, 27 (01) : 59 - 61
  • [3] Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis
    Roberts, WL
    Hariprashad, J
    Rainey, PM
    Murray, HW
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 55 (04): : 444 - 446
  • [4] Lysis syndrome during therapy of visceral leishmaniasis
    E. N. Liberopoulos
    A. A. Kei
    M. S. Elisaf
    Infection, 2012, 40 : 121 - 123
  • [5] Lysis syndrome during therapy of visceral leishmaniasis
    Liberopoulos, E. N.
    Kei, A. A.
    Elisaf, M. S.
    INFECTION, 2012, 40 (02) : 121 - 123
  • [6] PHARMACOKINETICS OF ANTIMONY DURING TREATMENT OF VISCERAL LEISHMANIASIS WITH SODIUM STIBOGLUCONATE OR MEGLUMINE ANTIMONIATE
    CHULAY, JD
    FLECKENSTEIN, L
    SMITH, DH
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1988, 82 (01) : 69 - 72
  • [7] Regulation of PKC Mediated Signaling by Calcium during Visceral Leishmaniasis
    Roy, Nivedita
    Chakraborty, Supriya
    Chowdhury, Bidisha Paul
    Banerjee, Sayantan
    Halder, Kuntal
    Majumder, Saikat
    Majumdar, Subrata
    Sen, Parimal C.
    PLOS ONE, 2014, 9 (10):
  • [8] PHARMACOKINETICS OF ANTIMONY DURING SODIUM STIBOGLUCONATE THERAPY FOR CUTANEOUS LEISHMANIASIS
    PAMPLIN, CL
    DESJARDINS, R
    CHULAY, J
    TRAMONT, E
    HENDRICKS, L
    CANFIELD, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 270 - 271
  • [9] Cutaneous and visceral leishmaniasis during anti-TNFα therapy
    Guarneri C.
    Bevelacqua V.
    Patterson J.W.
    Tchernev G.
    Wiener Medizinische Wochenschrift, 2017, 167 (3-4) : 78 - 82
  • [10] Combination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral leishmaniasis in hamsters
    Pal, C
    Raha, M
    Basu, A
    Roy, KC
    Gupta, A
    Ghosh, M
    Sahu, NP
    Banerjee, S
    Mandal, NB
    Bandyopadhyay, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 259 - 261
12345